Lytix Biopharma: Annual Report for 2022 ...Middle East

OSLO, Norway, March 30, 2023 /PRNewswire/ -- Lytix Biopharma AS ("Lytix") (Euronext Growth Oslo: LYTIX), a clinical stage immuno-oncology company, announces that it has published its Annual Report for 2022, which was approved by the board of directors on March 29, 2023. "In the course of...

Hence then, the article about lytix biopharma annual report for 2022 was published today ( Thursday 30/03/2023 - 09:17 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lytix Biopharma: Annual Report for 2022 )

Also on site :

• China’s EV Exports Soar by 87%
• NYSE Content Advisory: Pre-Market Update + S&P 500 To End 2025 Trade This Week, Up 18% So Far This Year
• ECARX Announces US$23 Million Strategic Investment in Lotus Technology to Deepen Global Partnership